Literature DB >> 5480849

Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

A E Broadus, N I Kaminsky, J G Hardman, E W Sutherland, G W Liddle.   

Abstract

Kinetic parameters and the renal clearances of plasma adenosine 3',5'-monophosphate (cyclic AMP) and guanosine 3',5'-monophosphate (cyclic GMP) were evaluated in normal subjects using tritium-labeled cyclic nucleotides. Each tracer was administered both by single, rapid intravenous injection and by constant intravenous infusion, and the specific activities of the cyclic nucleotides in plasma and urine were determined. Both cyclic AMP and cyclic GMP were cleared from plasma by glomerular filtration. The kidney was found to add a variable quantity of endogenous cyclic AMP to the tubular urine, amounting to an average of approximately one-third of the total level of cyclic AMP excreted. Plasma was the source of virtually all of the cyclic GMP excreted. Plasma levels of the cyclic nucleotides appeared to be in dynamic steady state. The apparent volumes of distribution of both nucleotides exceeded extracellular fluid volume, averaging 27 and 38% of body weight for cyclic AMP and cyclic GMP, respectively. Plasma production rates ranged from 9 to 17 nmoles/min for cyclic AMP and from 7 to 13 nmoles/min for cyclic GMP. Plasma clearance rates averaged 668 ml/min for cyclic AMP and 855 ml/min for cyclic GMP. Approximately 85% of the elimination of the cyclic nucleotides from the circulation was due to extrarenal clearance.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5480849      PMCID: PMC322723          DOI: 10.1172/JCI106441

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  DETERMINATION OF KINETIC PARAMETERS INA TWO-POOL SYSTEM BY ADMINISTRATION OF ONE OR MORE TRACERS.

Authors:  E GURPIDE; J MANN; E SANDBERG
Journal:  Biochemistry       Date:  1964-09       Impact factor: 3.162

2.  Adenyl cylase. I. Distribution, preparation, and properties.

Authors:  E W SUTHERLAND; T W RALL; T MENON
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

4.  Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.

Authors:  R W Butcher; C E Baird; E W Sutherland
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

5.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  Measurement of guanosine 3',5'-monophosphate and other cyclic nucleotides. Variations in urinary excretion with hormonal state of the rat.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1966-10-25       Impact factor: 5.157

7.  Organophosphates of urine, including adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.

Authors:  T D Price; D F Ashman; M M Melicow
Journal:  Biochim Biophys Acta       Date:  1967-05-30

8.  Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3',5'-monophosphate from guanosine trihosphate.

Authors:  J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

9.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

10.  Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine.

Authors:  R W Butcher; R J Ho; H C Meng; E W Sutherland
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

View more
  63 in total

1.  Urinary excretion of cyclic AMP in bacterial infections.

Authors:  W J Sibbald; V M Sardesai; A Short; R F Wilson
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

2.  Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.

Authors:  E R Heikkinen; S Similä; V V Myllylä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975-11-13

3.  Hepatic clearance of adenosine 3:5-cyclic monophosphate from plasma in the rat.

Authors:  R C Strange; I W Robb
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

4.  Studies of the elevated extracellular concentration of cyclic AMP in uremic man.

Authors:  P Hamet; D A Stouder; H E Ginn; J G Hardman; G W Liddle
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

5.  Lack of effect of phototherapy on plasma cyclic-AMP in newborn infants.

Authors:  A Constantopoulos; K Karaboula; N Matsaniotis
Journal:  Arch Dis Child       Date:  1977-05       Impact factor: 3.791

6.  cAMP content in rat urine following 10 and 20 days oral administration of a calcium-binding ion exchanger.

Authors:  R Markstein; V Hagmaier; M Häberle; B Kremer; G Rutishauser
Journal:  Urol Res       Date:  1979-12

7.  Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women.

Authors:  B B Fredholm; N O Lunell; B Persson; J Wager
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

8.  Tyramine kinetics and metabolism in cirrhosis.

Authors:  B A Faraj; J T Fulenwider; E B Rypins; B Nordlinger; G L Ivey; R D Jansen; F M Ali; V M Camp; M Kutner; F Schmidt; D Rudman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.

Authors:  A J Fairfax; M Rehahn; D Jones; B O'Malley
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.